Messenger RNA immunogens for initiation of HIV V3-glycan neutralizing B cell lineages — Barton F. Haynes (DUKE UNIVERSITY)
A key goal of HIV-1 vaccine development is to induce long-lasting broadly neutralizing antibodies (bnAbs) that can inhibit HIV-1 infection. Messenger (m) RNA has emerged as a promising new vaccine mod
| Project title | Messenger RNA immunogens for initiation of HIV V3-glycan neutralizing B cell lineages |
|---|---|
| Project number | 5U19AI135902-05 |
| PI name | Barton F. Haynes |
| Institution | DUKE UNIVERSITY |
| Funding mechanism | U19 |
| Agency | NIAID |
| Award amount | $6.18M |
| Fiscal year | 2022 |
| Project start | 2018-02-08T00:00:00 |
| Project end | 2026-01-31T00:00:00 |
| Abstract | A key goal of HIV-1 vaccine development is to induce long-lasting broadly neutralizing antibodies (bnAbs) that can inhibit HIV-1 infection. Messenger (m) RNA has emerged as a promising new vaccine mod |
| Key terms | <AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Af |
$799/mo
Try GrantRadar →